SCHEMBL5064548

SCHEMBL5064548

CCOc1cc2c(cc1OC)C(c1ccc(S(=O)(=O)N(C)CCOC)cc1)=NC1CCC(O)CC21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 5/20 0.49
PDE4A P27815 2/20 0.49
PDE4B Q07343 2/20 0.49
PDE4C Q08493 2/20 0.49
ALDH1A1 P00352 3/20 0.35
CA1 P00915 3/20 0.35
CA2 P00918 3/20 0.35
CA7 P43166 3/20 0.35
CA9 Q16790 3/20 0.35
CA14 Q9ULX7 3/20 0.35
CASP3 P42574 1/20 0.33
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MAPT P10636 1/20 0.32
CDK2 P24941 1/20 0.32
LMNA P02545 1/20 0.32
PDK1 Q15118 1/20 0.31
PDK2 Q15119 1/20 0.31
PDK3 Q15120 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5058953 0.88 PDE4D (0.51) PDE4DPDE4APDE4BPDE4CALDH1A1
SCHEMBL5067984 0.84 PDE4D (0.45) PDE4DPDE4APDE4BPDE4CALDH1A1
SCHEMBL6390285 0.81 PDE4D (0.52) PDE4DPDE4APDE4BPDE4CKDM4E
SCHEMBL5479126 0.81 PDE4D (0.52) PDE4DPDE4APDE4BPDE4CCA1
SCHEMBL15456672 0.80 PDE4D (0.52) PDE4DPDE4APDE4BPDE4C
SCHEMBL15456671 0.80 PDE4D (0.52) PDE4DPDE4APDE4BPDE4C
SCHEMBL5484482 0.80 PDE4D (0.74) PDE4DPDE4APDE4BPDE4CHPGD
SCHEMBL2265927 0.80 PDE4D (0.51) PDE4DPDE4APDE4BPDE4CALDH1A1
SCHEMBL5477891 0.80 PDE4B (0.49) PDE4DPDE4APDE4BPDE4CMAPT
SCHEMBL5058905 0.80 PDE4D (0.49) PDE4DPDE4APDE4BPDE4CALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080161339-A1 Novel Thio-Containing Hydroxy-6-Phenylphenanthridines and their Use as Pde4 Inhibitors ALTANA PHARMA AG (DE) 2008-07-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161339-A1 Novel Thio-Containing Hydroxy-6-Phenylphenanthridines and their Use as Pde4 Inhibitors PDE4A, PDE4B, PDE4C PDE4D 4/4885PDE4A 1/4885PDE4B 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.